Expert Opinion on the Management of Hyperkalemia in Patients with Cardiorenal Diseases Treated with Renin Angiotensin Aldosterone System Inhibitors: An Indonesian Perspective

Hyperkalemia (serum potassium >5.0 mEq/l) is a significant complication in patients with heart failure, chronic kidney disease, and diabetes mellitus, particularly when treated with renin-angiotensin-aldosterone system inhibitors (RAASi). Both hyperkalemia and RAASi interruption are associated with...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Pringgodigdo Nugroho, Aida Lydia, Haerani Abdul Rasyid, Zulkhair Ali, Pranawa, Nyoman Paramita Ayu, Birry Karim, Erwin Sukandi, Siti Elkana Nauli, Hary Sakti Muliawan, Edrian Zulkarnain
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Interna Publishing 2026-04-01
Edice:	Acta Medica Indonesiana
Témata:	Hyperkalemia Cardio-Renal Syndrome Renin-Angiotensin System Indonesia
On-line přístup:	https://actamedindones.org/index.php/ijim/article/view/3231
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!